Latest Industry Insights
Bridging the Gap Between In Vitro and Animal Models of Liver Disease
We spoke to Dr. Audrey Dubourg, product manager at CN Bio to find out more about how its organ-on-chip platform could bridge the gap between the current 2D models and animal models, providing human-relevant insights into diseases such as non-alcoholic steatohepatitis.
Alzheimer’s Breakthrough: A Disruptive Systemic Approach Is Poised To Demonstrate Value
Today’s treatments for AD are limited and unsatisfactory. This article explores a drug development effort that is taking a completely different approach – not trying to cure the disease but actually repair the damage.
The Impact of Funding on Longevity Research
To find out more about how early-stage funding could improve longevity research, we had the pleasure of speaking to Garri Zmudze, executive director of the Longevity Science Foundation.
How Researchers Are Bringing Sustainability to Scientific Discovery
Research is advancing exciting areas of science at an unprecedented pace, but the disposable materials, powered equipment and shipping associated with experiments, sample storage and transport of reagents contribute to high energy consumption and significant waste. How are researchers bringing sustainability to scientific discovery?
OPC UA for Sample Process Automation – Improving Data Harmonization for Biobanks and Cell and Gene Therapies
Technology Networks had the pleasure of talking to Wilfredo Marín to learn more about OPC UA and how it is suited to biobanking and cell and gene therapy development.
Digital Evolution: How Computer Science and AI Are Driving Microscopy Innovation and Advancing Life Sciences
This article explores how automated tools are helping researchers to algorithmically “unmix” spectral ranges – producing faster, smarter and higher-quality data and providing new possibilities for interpreting image data.
New Model Will Support Drug Discovery for Liver Disease NASH
To learn more about NASH “in-a-box” and how it can help to advance drug discovery for NASH, Technology Networks spoke to Dr. Audrey Dubourg.
The Spotlight on mRNA: A Conversation With Moderna
Technology Networks had the pleasure of interviewing Sunny Himansu M.B.B.S., D.SM – associate director, infectious diseases at Moderna – to discuss the biotech company's pipeline, how a collaboration with IAVI aims to make mRNA-based preventives and therapeutics globally accessible and the future of mRNA in medicine.
Optimizing Electroporation for Cell Therapy Development
Technology Networks had the pleasure of speaking with Thermo Fisher Scientific’s Don Paul Kovarcik, to learn more about the benefits and limitations of electroporation and key factors affecting electroporation performance.
How Restoring Brain Plasticity Is the Secret to Reversing Brain Damage
For the world’s leading neuroscientists, unlocking the brain’s capacity to stimulate neural plasticity has become something of a Holy Grail. In this Insight, NervGen Pharma president and CEO Paul Brennan details why plasticity is so important for the brain.